Skip to Main Content

Author Details

Johanna S M Mattsson
Uppsala University
2000
60
21
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37382890Tumor Heterogeneity Confounds Lymphocyte Metrics in Diagnostic Lung Cancer Biopsies.Arch Pathol Lab Med2024
36724681An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers.EBioMedicine2023
37349623Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases.Virchows Arch2023
37341056Expression of cancer-testis antigens in the immune microenvironment of non-small cell lung cancer.Mol Oncol2023
36963351Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer.Eur J Cancer2023
36636421Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas.Transl Lung Cancer Res2022
35429913Highly elevated systemic inflammation is a strong independent predictor of early mortality in advanced non-small cell lung cancer.Cancer Treat Res Commun2022
33310622Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancer.Lung Cancer2021
33576873PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung.Cancer Immunol Immunother2021
33706249The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types.EBioMedicine2021
33670619Education Satisfaction among Pharmacy Graduates in Sweden.Pharmacy (Basel)2021
33984662FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response.Eur J Cancer2021
34206510Plasma Proteomic Analysis in Non-Small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Blockade.Cancers (Basel)2021
34339045Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer.J Pathol2021
33257846Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene.Cell Death Differ2021
32491279Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non-small cell lung cancer.Cancer Med2020
31913660Diagnostic Value of Insulinoma-Associated Protein 1 (INSM1) and Comparison With Established Neuroendocrine Markers in Pulmonary Cancers.Arch Pathol Lab Med2020
32722156Job Satisfaction among Swedish Pharmacists.Pharmacy (Basel)2020
30639618Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLC.J Thorac Oncol2019
31183601Assessment of potentially inappropriate medications using the EU (7)-PIM list and the Swedish quality indicators.Int J Clin Pharm2019
31557791Swedish Pharmacy Students' Expectations and Perceptions of Their Education and Future Pharmacy Profession.Pharmacy (Basel)2019
31200831c-MET as a biomarker in patients with surgically resected non-small cell lung cancer.Lung Cancer2019
30926355Programmed Cell Death Ligand 1 Immunohistochemistry: A Concordance Study Between Surgical Specimen, Biopsy, and Tissue Microarray.Clin Lung Cancer2019
30885352Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11.Lung Cancer2019
30718697Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer.Sci Rep2019
30389437Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.Hum Pathol2019
28870444Pharmacists' satisfaction with their work: Analysis of an alumni survey.Res Social Adm Pharm2018
29876935An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancer.J Pathol2018
30169783Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases.Am J Clin Pathol2018
30429015Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer.Lung Cancer2018
30314534Who enrols and graduates from web-based pharmacy education - Experiences from Northern Sweden.Curr Pharm Teach Learn2018
29361941Physicians' perspectives on clinical pharmacy services in Northern Sweden: a qualitative study.BMC Health Serv Res2018
29667169Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer.Int J Cancer2018
29439013Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid-Mediated Pretargeting: In Vivo Proof of Principle.J Nucl Med2018
29140138COX-2 expression and effects of celecoxib in addition to standard chemotherapy in advanced non-small cell lung cancer.Acta Oncol2018
28818916A pathology atlas of the human cancer transcriptome.Science2017
28281552Reaching the limits of prognostication in non-small cell lung cancer: an optimized biomarker panel fails to outperform clinical parameters.Mod Pathol2017
28273850Chitosan-Based Nanomedicine to Fight Genital Candida Infections: Chitosomes.Mar Drugs2017
28970459Students' Satisfaction with a Web-Based Pharmacy Program in a Re-Regulated Pharmacy Market.Pharmacy (Basel)2017
28535939Gene Expression Profiling of Large Cell Lung Cancer Links Transcriptional Phenotypes to the New Histological WHO 2015 Classification.J Thorac Oncol2017
26872818The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs.J Thorac Oncol2016
26447895Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.Appl Immunohistochem Mol Morphol2016
27699219Profiling cancer testis antigens in non-small-cell lung cancer.JCI Insight2016
27495736Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer.BMC Cancer2016
27220803Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy.Br J Clin Pharmacol2016
27402990Using a Virtual Tablet Machine to Improve Student Understanding of the Complex Processes Involved in Tablet Manufacturing.Am J Pharm Educ2016
25574737Chitosan in mucoadhesive drug delivery: focus on local vaginal therapy.Mar Drugs2015
26354930HaloPlex Targeted Resequencing for Mutation Detection in Clinical Formalin-Fixed, Paraffin-Embedded Tumor Samples.J Mol Diagn2015
26608184Identification of sample annotation errors in gene expression datasets.Arch Toxicol2015
25971870Endoscopic papillectomy and KRAS expression in the treatment of adenoma in the major duodenal papilla.Scand J Gastroenterol2015
  • 1 - 50 of 60

Recommended Authors

the First Affiliated Hospital of Guangzhou Medical University
Career Start Year 2013
Number of shared co-authors 0
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
Career Start Year 2013
Number of shared co-authors 0
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 0
Department of Pharmacy, 5Peter MacCallum Cancer Centre
Career Start Year 2011
Number of shared co-authors 0
St. Michael's Hospital, University of Toronto
Career Start Year 2011
Number of shared co-authors 0
Center for Nanomedicine, Brigham and Women's Hospital
Career Start Year 2007
Number of shared co-authors 0
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 0
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year 2005
Number of shared co-authors 0
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 1
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 0
The First People's Hospital of Zhaoqing
Career Start Year 2003
Number of shared co-authors 0
University of Colorado Anschutz Medical Campus
Career Start Year 2001
Number of shared co-authors 0
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
The University of Manchester
Career Start Year 2000
Number of shared co-authors 0
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences
Career Start Year 1998
Number of shared co-authors 0
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Career Start Year 1997
Number of shared co-authors 0
St Vincent's Hospital
Career Start Year 1997
Number of shared co-authors 0
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 0
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 0
Stanford University
Career Start Year 1996
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1996
Number of shared co-authors 1
Norris Comprehensive Cancer Center, University of Southern California
Career Start Year 1995
Number of shared co-authors 0
Olivia Newton-John Cancer Research Institute
Career Start Year 1993
Number of shared co-authors 0
The Princess Margaret Cancer Centre/University of Toronto
Career Start Year 1992
Number of shared co-authors 1
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 0
Princess Margaret Cancer Centre
Career Start Year 1991
Number of shared co-authors 0
Institute of Pathology, Heidelberg University Hospital
Career Start Year 1991
Number of shared co-authors 0
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
Peter MacCallum Cancer Centre
Career Start Year 1973
Number of shared co-authors 0
University Health Network, University of Toronto
Career Start Year 1972
Number of shared co-authors 1

Collaborators

Uppsala University
Co-authored papers 42
Lund University
Co-authored papers 25
Lund University
Co-authored papers 17
Uppsala University
Co-authored papers 12
Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund
Co-authored papers 10
Yale University School of Medicine
Co-authored papers 9
Uppsala University
Co-authored papers 8
TU Dortmund University
Co-authored papers 6
KTH Royal Institute of Technology
Co-authored papers 3
Uppsala University
Co-authored papers 3
Uppsala University
Co-authored papers 3
Stockholm University
Co-authored papers 2
Uppsala University
Co-authored papers 2
Co-authored papers 2
KTH Royal Institute of Technology
Co-authored papers 2
KTH Royal Institute of Technology
Co-authored papers 2
Istanbul University
Co-authored papers 1
KTH Royal Institute of Technology
Co-authored papers 1
Uppsala University
Co-authored papers 1
KTH - Royal Institute of Technology, Sweden AIVIVO Ltd. Unit 25
Co-authored papers 1
Karolinska Institutet
Co-authored papers 1
Ohu University School of Pharmaceutical Sciences
Co-authored papers 1
KTH-Royal Institute of Technology
Co-authored papers 1
Columbia University
Co-authored papers 1
KTH-Royal Institute of Technology
Co-authored papers 1
KTH Royal Institute of Technology
Co-authored papers 1
Shulan International Medical College, Zhejiang Shuren University
Co-authored papers 1
Linkoping University
Co-authored papers 1
Umea University
Co-authored papers 1
Stockholm University
Co-authored papers 1